Effectiveness of Electroconvulsive Therapy in Patients With Advanced Parkinson Disease
Effectiveness of Electroconvulsive Therapy in Patients With Advanced Parkinson Disease
复制标题
电休克治疗晚期帕金森病患者的有效性
DOI:
10.1097/yct.0000000000000732
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Kawanishi Chiaki
中科院分区:
文献类型:
--
作者:
Murayama Tomonori;Kobayashi Seiju;Matsuoka Takeshi;Kigawa Yoshiyasu;Ishida Tomotaka;Hyakumachi Kengo;Utsumi Kumiko;Kawanishi Chiaki
ObjectivesIn addition to motor symptoms, patients with Parkinson disease (PD) experience various psychiatric comorbidities, including impulse control disorders (ICDs). Moreover, antiparkinsonian drugs sometimes cause psychiatric symptoms. Antiparkinsonian and antipsychotic drugs are competitive in pharmacodynamics, and psychotropic drugs, including antidepressants, may worsen motor symptoms or induce adverse reactions. Considering this conflicting situation, we examined the effectiveness of electroconvulsive therapy (ECT) on both motor and psychiatric symptoms in PD.MethodsWe retrospectively examined 12 PD patients with advanced motor symptoms and drug-resistant psychiatric symptoms, including ICDs, who had undergone ECT. Both before and after ECT, the severity of PD motor symptoms were evaluated using Hoehn and Yahr staging, while psychiatric symptoms were evaluated using the Neuropsychiatric Inventory. The patients' doses of antiparkinsonian and antipsychotic drugs were also assessed before and after ECT.ResultsBoth the mean Hoehn and Yahr and Neuropsychiatric Inventory scores were significantly decreased after ECT. The symptoms of ICDs, which were observed in 5 patients, disappeared following ECT. Improvements in motor symptoms and psychiatric symptoms lasted for more than 1 year in 5 cases and 9 cases, respectively. Furthermore, the daily dose of antiparkinsonian drugs was significantly decreased in 6 cases.ConclusionsOur results demonstrated that ECT was effective for both severe motor symptoms and psychiatric symptoms in advanced PD patients. ECT might be a solution for the conflicting problem of treating both motor and psychiatric symptoms in PD.
登录
查看更多内容
DOI:
10.1176/jnp.3.4.405
发表时间:
1991
期刊:
The Journal of neuropsychiatry and clinical neurosciences
影响因子:
--
作者:
G. Figiel;M. Hassen;C. Zorumski;K. Krishnan;P. Doraiswamy;M. Jarvis;Deborah S. Smith
通讯作者:
Deborah S. Smith
DOI:
10.1176/ajp.146.11.1451
发表时间:
1989
期刊:
The American journal of psychiatry
影响因子:
--
作者:
R. Douyon;M. Serby;B. Klutchko;J. Rotrosen
通讯作者:
J. Rotrosen
影响因子:
3.3
作者:
J. Balldin;A. Granérus;G. Lindstedt;K. Modigh;J. Wålinder
通讯作者:
J. Wålinder
DOI:
10.1097/00124509-200603000-00012
发表时间:
2006
期刊:
The Journal of ECT
影响因子:
--
作者:
C. Swartz
通讯作者:
C. Swartz
DOI:
--
发表时间:
1997
期刊:
Convulsive Therapy
影响因子:
--
作者:
D. Aarsland;Larsen Jp;O. Waage;Langeveld Jh
通讯作者:
Langeveld Jh